Literature DB >> 7826832

The pharmacokinetics of chloroquine in healthy Thai subjects and patients with Plasmodium vivax malaria.

K Na-Bangchang1, L Limpaibul, A Thanavibul, P Tan-Ariya, J Karbwang.   

Abstract

The pharmacokinetics of chloroquine (CQ) and desethylchloroquine (DECQ) were studied in seven male Thai patients with P. vivax malaria and seven healthy male Thais, after the standard oral dosage regimen of CQ (a total dose of 1500 mg given over 3 days). All patients showed a rapid initial response to the treatment with median (range) values of fever and parasite clearance times of 13.7 (2-47) and 58 (33-38) h, respectively. In the patients, the median range Cmax value was significantly higher (1547 (996-2446) vs 838 (656-1587) ng ml-1), and AUC(0,28d) was greater (281 (250-515) vs 122 (103-182) micrograms ml-1 h). In addition, the median (AUC(0,28d) of DECQ was significantly greater (170 (72-265) vs 77 (49-140) micrograms ml-1 h). The AUC(0,28d) ratio of DECQ to CQ in patients was significantly higher than that in healthy subjects (0.67 (0.43-0.90) vs 0.51 (0.29-0.61)).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7826832      PMCID: PMC1364802          DOI: 10.1111/j.1365-2125.1994.tb04354.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Chloroquine-resistant Plasmodium vivax from Indonesia.

Authors:  I K Schwartz; E M Lackritz; L C Patchen
Journal:  N Engl J Med       Date:  1991-03-28       Impact factor: 91.245

2.  Chloroquine-resistant Plasmodium vivax.

Authors:  M Whitby; G Wood; J R Veenendaal; K Rieckmann
Journal:  Lancet       Date:  1989-12-09       Impact factor: 79.321

3.  A mixed infection of vivax and falciparum malaria apparently resistant to 4-aminoquinoline: a case report.

Authors:  G J Schuurkamp; P E Spicer; R K Kereu; P K Bulungol
Journal:  Trans R Soc Trop Med Hyg       Date:  1989 Sep-Oct       Impact factor: 2.184

4.  Determination of chloroquine and its desethyl metabolite in plasma, red blood cells and urine by liquid chromatography.

Authors:  G Alván; L Ekman; B Lindström
Journal:  J Chromatogr       Date:  1982-04-16

5.  Development of in vitro microtest for the assessment of Plasmodium vivax sensitivity to chloroquine.

Authors:  C R Brockelman; P Tan-Ariya; D Bunnag
Journal:  Southeast Asian J Trop Med Public Health       Date:  1989-03       Impact factor: 0.267

6.  Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia.

Authors:  J K Baird; H Basri; M J Bangs; B Subianto; L C Patchen; S L Hoffman
Journal:  Am J Trop Med Hyg       Date:  1991-05       Impact factor: 2.345

7.  On the question of dose-dependent chloroquine elimination of a single oral dose.

Authors:  L L Gustafsson; L Rombo; G Alván; A Björkman; M Lind; O Walker
Journal:  Clin Pharmacol Ther       Date:  1983-09       Impact factor: 6.875

8.  Distribution of chloroquine and its metabolite desethyl-chloroquine in human blood cells and its implication for the quantitative determination of these compounds in serum and plasma.

Authors:  Y Bergqvist; B Domeij-Nyberg
Journal:  J Chromatogr       Date:  1983-01-14

9.  Pharmacokinetics of chloroquine in Thais: plasma and red-cell concentrations following an intravenous infusion to healthy subjects and patients with Plasmodium vivax malaria.

Authors:  G Edwards; S Looareesuwan; A J Davies; Y Wattanagoon; R E Phillips; D A Warrell
Journal:  Br J Clin Pharmacol       Date:  1988-04       Impact factor: 4.335

10.  Chloroquine-resistant Plasmodium vivax in Papua New Guinea.

Authors:  G J Schuurkamp; P E Spicer; R K Kereu; P K Bulungol; K H Rieckmann
Journal:  Trans R Soc Trop Med Hyg       Date:  1992 Mar-Apr       Impact factor: 2.184

View more
  16 in total

1.  Pharmacokinetics, pharmacodynamics, and allometric scaling of chloroquine in a murine malaria model.

Authors:  Brioni R Moore; Madhu Page-Sharp; Jillian R Stoney; Kenneth F Ilett; Jeffrey D Jago; Kevin T Batty
Journal:  Antimicrob Agents Chemother       Date:  2011-06-06       Impact factor: 5.191

Review 2.  Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements.

Authors:  J Ducharme; R Farinotti
Journal:  Clin Pharmacokinet       Date:  1996-10       Impact factor: 6.447

Review 3.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

4.  Pharmacokinetics of chloroquine and monodesethylchloroquine in pregnancy.

Authors:  Harin A Karunajeewa; Sam Salman; Ivo Mueller; Francisca Baiwog; Servina Gomorrai; Irwin Law; Madhu Page-Sharp; Stephen Rogerson; Peter Siba; Kenneth F Ilett; Timothy M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

5.  Pharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria.

Authors:  Harin A Karunajeewa; Kenneth F Ilett; Ivo Mueller; Peter Siba; Irwin Law; Madhu Page-Sharp; Enmoore Lin; Jovitha Lammey; Kevin T Batty; Timothy M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2007-10-29       Impact factor: 5.191

6.  Effect of Khat (Catha edulis) Use on the Bioavailability, Plasma Levels and Antimalarial Activity of Chloroquine.

Authors:  Faiza H Issa; Molhem Al-Habori; Michael L Chance
Journal:  Sultan Qaboos Univ Med J       Date:  2016-05-15

7.  Paracetamol disposition in Thai patients during and after treatment of falciparum malaria.

Authors:  S Ismail; K Na Bangchang; J Karbwang; D J Back; G Edwards
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

8.  Effects of Plasmodium berghei infection on cytochromes P-450 2E1 and 3A2.

Authors:  K Uhl; J M Grace; D A Kocisko; B T Jennings; A L Mitchell; T G Brewer
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Apr-Jun       Impact factor: 2.569

9.  Evaluation of pharmacokinetics of single-dose chloroquine in malnourished children with malaria- a comparative study with normally nourished children.

Authors:  Prashant P Kadam; Nithya Jaideep Gogtay; Sunil Karande; V Shah; Urmila M Thatte
Journal:  Indian J Pharmacol       Date:  2016 Sep-Oct       Impact factor: 1.200

10.  Comparison of the safety and efficacy of fixed-dose combination of arterolane maleate and piperaquine phosphate with chloroquine in acute, uncomplicated Plasmodium vivax malaria: a phase III, multicentric, open-label study.

Authors:  Neena Valecha; Deepali Savargaonkar; Bina Srivastava; B H Krishnamoorthy Rao; Santanu K Tripathi; Nithya Gogtay; Sanjay Kumar Kochar; Nalli Babu Vijaya Kumar; Girish Chandra Rajadhyaksha; Jitendra D Lakhani; Bhagirath B Solanki; Rajinder K Jalali; Sudershan Arora; Arjun Roy; Nilanjan Saha; Sunil S Iyer; Pradeep Sharma; Anupkumar R Anvikar
Journal:  Malar J       Date:  2016-01-27       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.